How is ambulatory monitoring and treadmill testing used in the management of Wolff-Parkinson-White (WPW) syndrome?

Updated: Jan 08, 2017
  • Author: Christopher R Ellis, MD, FACC, FHRS; Chief Editor: Mikhael F El-Chami, MD  more...
  • Print
Answer

Ambulatory monitoring and treadmill testing can provide additional noninvasive information if the preexcitation disappears suddenly at a discrete heart rate. However, care should be exercised in the interpretation of these noninvasive test results. Invasive risk assessment with subsequent RF ablation should be performed in patients who present with syncope or aborted SCD.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!